Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 430 of 684

Advanced search

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Munich’s biotech hub: Inside one of Europe’s leading life sciences ecosystems

Labiotech.euOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO

Fierce PharmaOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion

Indian Pharma PostOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Can Virtual Humans Transform Drug Discovery?

LabrootsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Biotech ETFs XBI and PBE diverge sharply in str...

PluangOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Drug packages get unique codes; Ridgetech unit elected to new role

Stock TitanOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association

Yahoo FinanceOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO

MedCity NewsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: BB Biotech says q2 portfolio beat sector as ai push advances

Investing.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock

Investing.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

ETF Showdown: XBI vs PBE, Which Biotech Fund Wins?

Yahoo FinanceOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift (NYSE:WST)

Seeking AlphaOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

What Prompted the Chief Legal Officer's Recent OLMA Share Sales

Kavout | AIOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

BB Biotech Q2 2026 slides: NAV surges 17%, 12 new investments added By Investing.com

Investing.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Organon's VTAMA Skin-Clearance Response Reached 56.3% in Ages 2–6 at Week 8

Stock TitanOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Jubilant Biosys Brings Together Global Biotech Leaders to Advance the Future of Healthcare Innovation at 2nd EDGE Innovation Forum

PR NewswireOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Federal Contracts for Biotech: Opportunities, With Strings Attached

FreshfieldsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

BION: Biotech outperformance fueled by M&A, clinical progress, and AI-driven productivity gains

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

What Does the FDA's PDUFA Extension Signal for Rhythm Pharmaceuticals

Kavout | AIOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc. (KRYS) stock price, news, quote and history

Yahoo Finance SingaporeOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

BMC Headquarters Canteen Sealed by Maharashtra FDA After Fly Found in Buttermilk, Operator’s Licence

LatestLYOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data

PharmTech.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Is Edgewise Therapeutics (EWTX) on the Cusp of a Breakthrough Year

Kavout | AIOriginal source

🇯🇵Jul 24Industrynippon-shinyaku.co.jpTier 1 · Company source

「第97回都市対抗野球大会」組み合わせ決定日本新薬は鹿嶋市代表「日本製鉄鹿島」と対戦

Nippon Shinyaku NewsOriginal source

🇺🇰Jul 24Regulatorygov.ukTier 1 · Regulatory source

Learning Support Fund 10th edition: 2026 to 2027

Information for academic authorities and students on pre-registration healthcare programmes in the 2...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 24Regulatorygov.ukTier 1 · Regulatory source

Learning Support Fund guidance

Information for academic authorities and students on pre-registration healthcare programmes that pro...

UK Department of Health and Social CareOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

STATOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development

Business WireOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Merck Inks Landmark Generic Licensing Deal for Monthly HIV Pill

streamlinefeed.co.keOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

PolyPid, Azurity Sign US$330M Deal for D-PLEX100

Streetwise ReportsOriginal source

🇺🇰Jul 24Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 26 July 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

REQUIREMENTS-FOR-THE-LISTING-OF-COSMETICS

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Gerresheimer opens new pharmaceutical glass packaging plant in China

Packaging GatewayOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

ZAMRA-Cosmetic-Guidelines-22Mar2023-v.LC-final-1

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

REG - Hikma Pharmaceutical - Holding(s) in Company

TradingViewOriginal source

🇩🇪Jul 24Researchuni-heidelberg.deTier 2 · Direct publisher

Centennial of International Summer School at Universität Heidelberg

Heidelberg UniversityOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics Poised to Disrupt the Weight-Loss Market

Kavout | AIOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

API FPP Assessment Template-LOQ_v0 – ZAZIBONA

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Active Biotech doses first patient in updated myelofibrosis study

BiostockOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical (CHGCF) Reports Strong First Half Earnings

GuruFocusOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

Roles of key players in Zazibona-process_v0 – ZAZIBONA

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, I (WST) Stock Forecasts

Yahoo FinanceOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma

PubMed Blood RSSOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A

PubMed Blood RSSOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Reply to: "Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?" and "Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?"

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 24Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group

PubMed Journal of Clinical Oncology RSSOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Cabio Biotech's Trading To Halt To Implement Risk Warning

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Sanofi gives up on amlitelimab in atopic dermatitis

pharmaphorumOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Healthcare Demand Upgrade, EPS Creative Health Technology Group (3860.HK) Expands Its Healthcare Business

TradingViewOriginal source

🇺🇰Jul 24Researched.ac.ukTier 2 · Direct publisher

Edinburgh athletes on the world stage at Commonwealth Games

University of EdinburghOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

UBS downgrades Legend Biotech stock rating on competition concerns

Investing.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Neurocrine bolsters senior ranks as it builds beyond Ingrezza

The Pharma LetterOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

FDA panel narrowly backs two peptides for compounding list

The Pharma LetterOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

UBS downgrades Legend Biotech stock rating on competition concerns

Investing.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Biotech stocks consolidate post-breakout with i...

PluangOriginal source

🇺🇰Jul 24Researchstgeorges.nhs.ukTier 2 · Direct publisher

World first gene therapy treats rare form of childhood blindness

St George's University HospitalsOriginal source

Pharmaceutical industry news

Munich’s biotech hub: Inside one of Europe’s leading life sciences ecosystems

Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO

Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion

Can Virtual Humans Transform Drug Discovery?

Biotech ETFs XBI and PBE diverge sharply in str...

Drug packages get unique codes; Ridgetech unit elected to new role

Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association

CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO

Earnings call transcript: BB Biotech says q2 portfolio beat sector as ai push advances

H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock

ETF Showdown: XBI vs PBE, Which Biotech Fund Wins?

West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift (NYSE:WST)

What Prompted the Chief Legal Officer's Recent OLMA Share Sales

BB Biotech Q2 2026 slides: NAV surges 17%, 12 new investments added By Investing.com

Organon's VTAMA Skin-Clearance Response Reached 56.3% in Ages 2–6 at Week 8

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

Jubilant Biosys Brings Together Global Biotech Leaders to Advance the Future of Healthcare Innovation at 2nd EDGE Innovation Forum

Federal Contracts for Biotech: Opportunities, With Strings Attached

BION: Biotech outperformance fueled by M&A, clinical progress, and AI-driven productivity gains

What Does the FDA's PDUFA Extension Signal for Rhythm Pharmaceuticals

Krystal Biotech, Inc. (KRYS) stock price, news, quote and history

BMC Headquarters Canteen Sealed by Maharashtra FDA After Fly Found in Buttermilk, Operator’s Licence

Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data

Is Edgewise Therapeutics (EWTX) on the Cusp of a Breakthrough Year

「第97回 都市対抗野球大会」組み合わせ決定 日本新薬は鹿嶋市代表「日本製鉄鹿島」と対戦

Learning Support Fund 10th edition: 2026 to 2027

Learning Support Fund guidance

SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating

Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development

Merck Inks Landmark Generic Licensing Deal for Monthly HIV Pill

PolyPid, Azurity Sign US$330M Deal for D-PLEX100

Weekly all-cause mortality surveillance: week ending 26 July 2026

REQUIREMENTS-FOR-THE-LISTING-OF-COSMETICS

Gerresheimer opens new pharmaceutical glass packaging plant in China

ZAMRA-Cosmetic-Guidelines-22Mar2023-v.LC-final-1

REG - Hikma Pharmaceutical - Holding(s) in Company

Centennial of International Summer School at Universität Heidelberg

Is Viking Therapeutics Poised to Disrupt the Weight-Loss Market

API FPP Assessment Template-LOQ_v0 – ZAZIBONA

Active Biotech doses first patient in updated myelofibrosis study

Chugai Pharmaceutical (CHGCF) Reports Strong First Half Earnings

Roles of key players in Zazibona-process_v0 – ZAZIBONA

West Pharmaceutical Services, I (WST) Stock Forecasts

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma

Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A

Reply to: "Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?" and "Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?"

Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?

Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?

AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group

Cabio Biotech's Trading To Halt To Implement Risk Warning

Sanofi gives up on amlitelimab in atopic dermatitis

Healthcare Demand Upgrade, EPS Creative Health Technology Group (3860.HK) Expands Its Healthcare Business

Edinburgh athletes on the world stage at Commonwealth Games

UBS downgrades Legend Biotech stock rating on competition concerns

Neurocrine bolsters senior ranks as it builds beyond Ingrezza

FDA panel narrowly backs two peptides for compounding list

UBS downgrades Legend Biotech stock rating on competition concerns

Biotech stocks consolidate post-breakout with i...

World first gene therapy treats rare form of childhood blindness

「第97回都市対抗野球大会」組み合わせ決定日本新薬は鹿嶋市代表「日本製鉄鹿島」と対戦